Abraxis BioScience, Inc. (ABII) reported thid-quarter GAAP net loss for common shareholders of $37.7 million or $0.94 per share, compared with net loss for common shareholders of $15.1 million or $0.38 per share in the third quarter of 2008.
Adjusted net loss for common shareholders for the third quarter was $24.2 million, or $0.60 per share, versus profit of $10.5 million or $0.26 per share in the year-ago quarter.
Net revenue for the quarter grew to $96.6 million from $93.4 million in the prior year quarter.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.